Embed this press release by copying the code below:

<a class="rwp-pr" href="http://rwire.com/470338">CEL-SCI Reports 146 Patients Enrolled in Its Phase III Immunotherapy Head and Neck Cancer Trial</a><script>!function(){var e="rwp-platform";if(!document.getElementById(e)){var t=document.createElement("script");t.id=e,t.src=("https:"===document.location.protocol?"https":"http")+"://publisher.releasewire.com/embed.js",t.async=!0,document.body.appendChild(t)}}();</script>

CEL-SCI Reports 146 Patients Enrolled in Its Phase III Immunotherapy Head and Neck Cancer Trial